Stay updated on Long-Term Safety of ASN002 in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Long-Term Safety of ASN002 in Atopic Dermatitis Clinical Trial page.
Latest updates to the Long-Term Safety of ASN002 in Atopic Dermatitis Clinical Trial page
- Check2 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4.SummaryDifference0.0%
- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedLocations sections were added and populated with study sites across Alabama, California, Florida, Indiana, Kentucky, Massachusetts, New Hampshire, New York, North Carolina, Ohio, Oklahoma, Pennsylvania, South Carolina, Texas, and Virginia. The page revision was updated to v3.3.3.SummaryDifference1%
- Check53 days agoChange DetectedPage footer revision updated from v3.2.0 to v3.3.2; no study content, eligibility criteria, or locations were changed, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%
- Check60 days agoChange DetectedRemoved the government funding lapse notice from the page; core study content and locations remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%
- Check81 days agoChange DetectedThe two screenshots show the same study details page with no meaningful updates to the study content or layout.SummaryDifference0.3%
- Check103 days agoChange DetectedUpdate includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.SummaryDifference3%
Stay in the know with updates to Long-Term Safety of ASN002 in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-Term Safety of ASN002 in Atopic Dermatitis Clinical Trial page.